Related Experiment Videos
Effect of hypercalcemia on the anion gap
J R Oster1, R Gutierrez, F B Schlessinger
1Medical Services, Veterans Administration Medical Center, Miami, Fla.
Nephron
|January 1, 1990
Summary
Hypercalcemia from parathyroid issues, not malignancy, significantly lowers the serum anion gap (AG). This finding is crucial for diagnosing hypercalcemia causes when the AG is low.
Area of Science:
- Nephrology
- Endocrinology
- Clinical Chemistry
Background:
- Hypercalcemia is often assumed to reduce the serum anion gap (AG) due to increased unmeasured cations.
- This assumption lacks robust documentation and requires clinical investigation.
Purpose of the Study:
- To investigate the relationship between hypercalcemia and serum anion gap (AG).
- To determine if hypercalcemia from different etiologies affects the AG differently.
- To assess the diagnostic utility of AG in differentiating causes of hypercalcemia.
Main Methods:
- Retrospective comparison of serum anion gap (AG) and calcium levels.
- Data analyzed from 59 hypercalcemic patients with malignancy, 108 with parathyroid hypercalcemia, and 51 controls.
- Statistical analysis to compare AG values and correlations with serum calcium and albumin.
Main Results:
- Patients with parathyroid hypercalcemia exhibited a significantly lower AG (8.7 mEq/l) compared to malignancy-related hypercalcemia (11.1 mEq/l) and controls (11.1 mEq/l).
- No significant correlation was found between AG and serum calcium in hypercalcemic patients.
- Differences in albumin, renal function, or acid-base status did not explain the AG variations.
Conclusions:
- Hypercalcemia associated with a reduced AG is characteristic of hyperparathyroidism, not malignancy-related hypercalcemia.
- The AG's diagnostic value for individual hypercalcemic patients is limited due to value overlap.
- A low AG (≤5 mEq/l) in hypercalcemic patients, excluding multiple myeloma, may suggest a non-malignant etiology.